Evidence map›Paper›PMID 42043751›Full record

ArticleClinical journal of gastroenterology2026

Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.

Kazuto Takahashi, Hidetaka Matsuda, Yosuke Murata, Yu Akazawa, Tomoko Tanaka, Takuto Nosaka, Tatsushi Naito, Masahiro Otani, Yoshiaki Imamura, Yasunari Nakamoto

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kazuto TakahashiDepartment of Gastroenterology, Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-Cho Yoshida-Gun, Fukui, 910-1193, Japan.ORCID http://orcid.org/0000-0003-4952-8714
Hidetaka MatsudaDepartment of Gastroenterology, Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-Cho Yoshida-Gun, Fukui, 910-1193, Japan.
Yosuke MurataDepartment of Gastroenterology, Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-Cho Yoshida-Gun, Fukui, 910-1193, Japan.
Yu AkazawaDepartment of Gastroenterology, Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-Cho Yoshida-Gun, Fukui, 910-1193, Japan.
Tomoko TanakaDepartment of Gastroenterology, Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-Cho Yoshida-Gun, Fukui, 910-1193, Japan.
Takuto NosakaDepartment of Gastroenterology, Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-Cho Yoshida-Gun, Fukui, 910-1193, Japan.
Tatsushi NaitoDepartment of Gastroenterology, Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-Cho Yoshida-Gun, Fukui, 910-1193, Japan.
Masahiro OtaniDepartment of Gastroenterology, Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-Cho Yoshida-Gun, Fukui, 910-1193, Japan.
Yoshiaki ImamuraDivision of Diagnostic Pathology/Surgical Pathology, University of Fukui Hospital, Fukui, Japan.
Yasunari NakamotoDepartment of Gastroenterology, Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-Cho Yoshida-Gun, Fukui, 910-1193, Japan. nakamoto-med2@med.u-fukui.ac.jp.ORCID http://orcid.org/0000-0002-3160-3555

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastric cancerImmune checkpoint inhibitorsMulti-organ immune-related adverse eventsTherapeutic efficacy

Identifiers

PMID42043751
PMCPMC13424544

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.